Buscar
Revvity Inc
RVTYAñadir a la lista de seguimiento
112.520USD
-1.020-0.90%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
12.55BCap. mercado
54.04P/E TTM
Más Datos de Revvity Inc Compañía
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Información de Revvity Inc
Símbolo de cotizaciónRVTY
Nombre de la empresaRevvity Inc
Fecha de salida a bolsaAug 12, 2101
Director ejecutivoSingh (Prahlad R)
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 12
Dirección77 4Th Avenue
CiudadWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Teléfono17816636900
Sitio Webhttps://www.revvity.com/
Símbolo de cotizaciónRVTY
Fecha de salida a bolsaAug 12, 2101
Director ejecutivoSingh (Prahlad R)
Ejecutivos de Revvity Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
15.98K
+14.26%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
13.96K
+25.23%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
7.37K
+30.94%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
7.37K
+30.94%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Revvity Inc?
Los cinco principales accionistas de Revvity Inc son: Dr. Prahlad R. Singh, Ph.D.
¿Cuántas instituciones poseen acciones de Revvity Inc (RVTY)?
A fecha de 2026Q1, 1187 instituciones poseen acciones de Revvity Inc, con un valor de mercado combinado de aproximadamente 116.42M, lo que representa el 104.13% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -12219072.00.